| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bddcd6acf3045faf42e8f7cf299dcc37 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10332
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10321 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-761 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-93 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-861
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate |
2012-02-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be5b7c0843e188be0e30ca34a0db43e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6605f8fabb27015d9b8ca62e9ce4d641
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e84d76bd1ce54fe5633e7c4a0688d4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c0f058647fcf8c09fe5c550338a059f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f32f0d2e9b5479c6593309e2c9d3a13b |
| publicationDate |
2019-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2716764-B1 |
| titleOfInvention |
Construction and application of mutant type b human adenovirus ad11 having enhanced oncolytic power |
| priorityDate |
2011-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |